What's Happening?
A cholesterol point-of-care testing pilot service in north east London has successfully screened over 550 patients across seven community pharmacies. The pilot, which ran from January to October 2025, was a collaboration between Barts Health NHS Trust,
NHS North East London, and other partners. It aimed to identify patients' cholesterol levels and assess their risk of heart problems using a seven-minute test. The evaluation showed that 24 participants started statins, while others opted for lifestyle changes. The service engaged mostly working-age adults, with a significant portion of patients from deprived areas.
Why It's Important?
This pilot highlights the potential of community pharmacies to play a crucial role in preventive healthcare. By offering accessible cholesterol testing, pharmacies can help identify individuals at risk of cardiovascular diseases earlier, potentially reducing long-term healthcare costs and improving patient outcomes. The service aligns with the NHS's ten-year plan for prevention, emphasizing the importance of early intervention in managing chronic health conditions. The pilot also underscores the need for culturally sensitive healthcare approaches, as patient engagement varied across different ethnic groups.
What's Next?
Following the pilot's conclusion, efforts are underway to continue the service and expand it to include HbA1c testing for diabetes risk assessment. The expansion to 70 pharmacies across London in January 2026 indicates a growing recognition of the value of point-of-care testing in community settings. Future developments may focus on addressing resource challenges to enable wider participation among pharmacies. Stakeholders are likely to advocate for broader implementation of such services to enhance preventive healthcare access.
